revlimid

Generic: lenalidomide

Labeler: celgene corporation
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name revlimid
Generic Name lenalidomide
Labeler celgene corporation
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

lenalidomide 5 mg/1

Manufacturer
Celgene Corporation

Identifiers & Regulatory

Product NDC 59572-405
Product ID 59572-405_b5eadec8-aa2b-43ec-b0d6-e5b0c3da08cb
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA021880
Listing Expiration 2026-12-31
Marketing Start 2005-12-27

Pharmacologic Class

Established (EPC)
thalidomide analog [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 59572405
Hyphenated Format 59572-405

Supplemental Identifiers

RxCUI
602910 602912 616114 616116 643712 643714 643720 643722 1242231 1242233 1428947 1429367
UNII
F0P408N6V4
NUI
N0000184014

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name revlimid (source: ndc)
Generic Name lenalidomide (source: ndc)
Application Number NDA021880 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 5 mg/1
source: ndc
Packaging
  • 100 CAPSULE in 1 BOTTLE (59572-405-00)
  • 28 CAPSULE in 1 BOTTLE (59572-405-28)
source: ndc

Packages (2)

59572-405-00 100 CAPSULE in 1 BOTTLE (59572-405-00) 59572-405-28 28 CAPSULE in 1 BOTTLE (59572-405-28)

Ingredients (1)

lenalidomide (5 mg/1)

Linked Drug Pages (1)

Revlimid ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "b5eadec8-aa2b-43ec-b0d6-e5b0c3da08cb", "openfda": {"nui": ["N0000184014"], "unii": ["F0P408N6V4"], "rxcui": ["602910", "602912", "616114", "616116", "643712", "643714", "643720", "643722", "1242231", "1242233", "1428947", "1429367"], "spl_set_id": ["5fa97bf5-28a2-48f1-8955-f56012d296be"], "pharm_class_epc": ["Thalidomide Analog [EPC]"], "manufacturer_name": ["Celgene Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (59572-405-00)", "package_ndc": "59572-405-00", "marketing_start_date": "20051227"}, {"sample": false, "description": "28 CAPSULE in 1 BOTTLE (59572-405-28)", "package_ndc": "59572-405-28", "marketing_start_date": "20090303"}], "brand_name": "Revlimid", "product_id": "59572-405_b5eadec8-aa2b-43ec-b0d6-e5b0c3da08cb", "dosage_form": "CAPSULE", "pharm_class": ["Thalidomide Analog [EPC]"], "product_ndc": "59572-405", "generic_name": "Lenalidomide", "labeler_name": "Celgene Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Revlimid", "active_ingredients": [{"name": "LENALIDOMIDE", "strength": "5 mg/1"}], "application_number": "NDA021880", "marketing_category": "NDA", "marketing_start_date": "20051227", "listing_expiration_date": "20261231"}